Jardiance is a prescription medication designed to aid in managing type 2 diabetes by effectively lowering blood sugar levels. Its active ingredient, empagliflozin, functions by inhibiting the sodium-glucose co-transporter 2 (SGLT2), which facilitates the excretion of excess glucose through urine. Apart from enhancing glycemic control, Jardiance may also contribute to reducing the risk of cardiovascular events in diabetic patients. The medication is available in two dosage strengths: 10 mg and 25 mg, packaged in strips containing 10 tablets each. It is important to follow your healthcare provider’s guidance regarding dosage and usage.